AxioMed Raises Additional $5M in Equity FinancingWritten by Jaimie Oh | June 14, 2012
AxioMed, a spinal orthopedics company, has completed the final closing of its Series D financing, raising $5 million in two tranches from current and new investors.
This funding augments the previously announced $15 million Series D financing.
AxioMed's Freedom Lumbar Disc is currently on the market in the EU and advancing toward completion of its Investigational Device Exemption pivotal study in the U.S. AxioMed intends to follow a similar regulatory and marketing pathway as the FLD with its Freedom Cervical Disc, which recently received a CE Mark for introduction in the EU.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.